JUPITER — Scripps Florida researcher Gavin Rumbaugh won a five-year, $3.6 million grant from the National Institute of Mental Health to continue studies of abnormal brain circuitry in autism, the nonprofit lab said Tuesday.
MORE “SCRIPPS FLORIDA RESEARCHERS WIN $3.6 MILLION NIH GRANT TO STUDY AUTISM”
Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal is to find ways to stop cancer cells from multiplying out of control, thereby blocking the growth and spread of tumors.
MORE “TUMOR-LIKE SPHERES HELP SCIENTISTS DISCOVER SMARTER CANCER DRUGS”
BOCA RATON, Fla.–(BUSINESS WIRE)–May 30, 2018– TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative Palm Beach County based women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. IMVEXXY is the only product in its therapeutic class to offer a 4 mcg and 10 mcg dose, the 4 mcg representing the lowest approved dose of vaginal estradiol available. “IMVEXXY is a drug which was conceived, formulated, developed, and now approved in Palm Beach County, a clear demonstration of our life sciences cluster’s resources to bring a product from bench to bedside,” said Kelly Smallridge, President of the Business Development Board.
MORE “THERAPEUTICSMD, INC. ANNOUNCES FDA APPROVAL OF TX-004HR: IMVEXXY”
PALM BEACH GARDENS — Palm Beach Gardens Medical Center named Trey Abshier its new chief executive officer this week.
MORE “PALM BEACH GARDENS MEDICAL CENTER GETS A NEW CEO AGAIN”
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–TD Solutions announced today that they have initiated development of Epi Mist™ HypoSpray Epinephrine for allergic reactions. More than 35 million Americans suffer from allergies and that number will continue to rise. Spot shortages of life-saving medication causes anxiety for patients and caregivers.
MORE “TD SOLUTIONS ANNOUNCES EPI MIST™ HYPOSPRAY® EPINEPHRINE”
If the “eyes are the window to the soul,” then a series of studies from a Florida Atlantic University laboratory suggests that they may also be a window into diagnosing and treating attention-deficit/hyperactivity disorder (ADHD) and other dopamine-linked neuropsychiatric disorders.
MORE “NEW METHOD PROPOSES TO DIAGNOSE DOPAMINE-LINKED DISORDERS”
Boca Raton, Fla. – May 7, 2018 – gMed®, a Modernizing Medicine® company, announced that GI Partners of Illinois and GI North have switched to the award-winning gGastro® electronic health record (EHR) system and suite of solutions. Both practices faced challenges with their previous EHR and opted to utilize gMed’s gastroenterology EHR, Practice Management and Endoscopy Report Writer to help address the Merit-based Incentive Payment System (MIPS)* and to have one integrated system across their practice locations.
BOCA RATON, FL – RELEASE PDF May 11, 2018 – Officials at Boca Raton Regional Hospital today announced that it has pared its list of potential strategic partners to two finalists; Baptist Health South Florida and Cleveland Clinic.
MORE “BOCA RATON REGIONAL HOSPITAL PARES POTENTIAL PARTNER LIST”
WEST PALM BEACH — They were novelists and scientists, playwrights and polyglots. Teenagers all, they gathered Thursday to bask in the collective glow of their supersized achievements at the 2018 Pathfinder High School Scholarship Awards.
MORE “STUDENTS FIND WINNING AT 35TH ANNUAL PATHFINDER AWARDS ‘SURREAL’”
